Alexandra De La Pena, | |
2401 Grove Ave Apt B, Richmond, VA 23220-4567 | |
(919) 606-0036 | |
Not Available |
Full Name | Alexandra De La Pena |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 2401 Grove Ave Apt B, Richmond, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548919814 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 0110-008529 (Virginia) | Secondary |
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexandra De La Pena, 2401 Grove Ave Apt B, Richmond, VA 23220-4567 Ph: (919) 606-0036 | Alexandra De La Pena, 2401 Grove Ave Apt B, Richmond, VA 23220-4567 Ph: (919) 606-0036 |
News Archive
For some Canadians, any cut such as from dental work or surgery can cause days or more of bleeding. Although they are not hemophiliacs, for some an ordinary bruise can balloon into the size of an orange.
HIV-positive mothers have been able to guard against transmitting the disease to their babies by taking antiretroviral drugs during pregnancy. Although the drugs prevent children from being born with HIV, they could cause birth defects, such as cleft lip and palate. A new study explores any links between antiretroviral prophylaxis and cleft lip and palate.
Prof. Lars Leksell (1907-1986), inventor of the radiosurgical instrument that bears his name and a faculty member of Karolinska University Hospital (Solna, Sweden), performed the world's first Gamma Knife® surgery at nearby Sophiahemmet Hospital, the location of the first Leksell Gamma Knife. Karolinska University Hospital recently acquired Elekta's fifth generation radiosurgery system, Leksell Gamma Knife® Perfexion™.
Young people and women are identified as target groups to aim tobacco packaging at according to a new Cancer Research UK report released on Thursday.
The next generation of drug therapies and enhanced treatment approaches for various forms of lymphoma are evolving as researchers continue to better understand how these cancers progress. Research will be presented today at the 52nd Annual Meeting of the American Society of Hematology introducing promising new options for the standard treatment of advanced asymptomatic follicular lymphoma, mantle cell lymphoma, and early, unfavorable (referring to patients with clinical stage I or II disease and one or more risk factors) Hodgkin disease.
› Verified 3 days ago